KAZIA THERAPEUTICS LTD (NASDAQ: KZIA) said paxalisib reduced total tumor burden by 52% in a preclinical model of MSS/pMMR colorectal cancer, with a result of p=0.035. A separate experiment found that adding the drug to immunotherapy cut tumor volume an additional 50% versus immunotherapy …
Merit Medical Systems Inc. (NASDAQ: MMSI) identifies Lewis Sheri as executive vice president of global operations. A Form 3 filing reports a new insider position for Sheri at the company.
Telix Pharmaceuticals Ltd completed patient enrollment in its BiPASS study, which evaluates prostate cancer imaging before biopsy. The company also aligned with the U.S. Food and Drug Administration on a New Drug Application pathway that, if approved, could support reimbursement as a new product …
TIMKEN CO (NYSE: TKR) named Stephen Philip Ribaudo executive vice president and chief operating officer while reporting his initial stake in the company. The reported ownership is held directly or indirectly.
IMC Rare Earths Ltd (AMEX: IMC). (AMEX: IMC) has registered the resale of 10,110,000 ordinary shares by Americas Rare Earths Holdings Ltd. with the shares issuable through warrants linked to the companies’ offtake relationship. The ordinary shares have aPar Valueof $0.0001 each. IMC Rare …
Caarapó Mill Moves Into Adecoagro’s Platform
GoPro, Inc. (NASDAQ: GPRO) would continue as the surviving corporation while becoming a subsidiary of Action Acquisitions LLC if the proposed merger closes. The agreement calls for Starman Optical, Inc. to merge into GoPro, subject to conditions that may be satisfied or waived where …
Liberty Live Holdings, Inc. will appoint Philip J. Boeckman as chief legal officer effective October 1, 2026, with responsibility for overseeing the company’s legal functions. Renee L. Wilm will move into the senior advisor role on the same date, continuing to counsel leadership and …
Basel Medical Group Ltd (NASDAQ: BMGL) is changing its board, with Raymond Fung Keng Leong and Darren Tan stepping down as directors with immediate effect. Yang Xinwen, Cao Juan and Frederick Hong have joined the board, while Tan continues as chief commercial officer.
Can-Fite BioPharma Ltd. (AMEX: CANF) expects approximately $4.0 million in gross cash proceeds from an immediateWarrantexercise, before placement fees and offering expenses. The transaction is subject to customary closing conditions and is expected to close on or about September 3, with net proceeds intended …